1. Home
  2. LOB vs EVO Comparison

LOB vs EVO Comparison

Compare LOB & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOB
  • EVO
  • Stock Information
  • Founded
  • LOB 2008
  • EVO 1993
  • Country
  • LOB United States
  • EVO Germany
  • Employees
  • LOB N/A
  • EVO N/A
  • Industry
  • LOB Major Banks
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOB Finance
  • EVO Health Care
  • Exchange
  • LOB Nasdaq
  • EVO Nasdaq
  • Market Cap
  • LOB 1.8B
  • EVO 1.5B
  • IPO Year
  • LOB 2015
  • EVO 2021
  • Fundamental
  • Price
  • LOB $41.10
  • EVO $4.14
  • Analyst Decision
  • LOB Buy
  • EVO Buy
  • Analyst Count
  • LOB 6
  • EVO 2
  • Target Price
  • LOB $45.67
  • EVO $5.90
  • AVG Volume (30 Days)
  • LOB 154.1K
  • EVO 200.1K
  • Earning Date
  • LOB 01-22-2025
  • EVO 11-06-2024
  • Dividend Yield
  • LOB 0.31%
  • EVO N/A
  • EPS Growth
  • LOB 39.66
  • EVO N/A
  • EPS
  • LOB 1.84
  • EVO N/A
  • Revenue
  • LOB $405,743,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • LOB N/A
  • EVO $3.89
  • Revenue Next Year
  • LOB $16.57
  • EVO $9.65
  • P/E Ratio
  • LOB $20.35
  • EVO N/A
  • Revenue Growth
  • LOB 9.13
  • EVO N/A
  • 52 Week Low
  • LOB $31.03
  • EVO $2.85
  • 52 Week High
  • LOB $50.57
  • EVO $8.39
  • Technical
  • Relative Strength Index (RSI)
  • LOB 43.56
  • EVO 43.05
  • Support Level
  • LOB $36.02
  • EVO $3.98
  • Resistance Level
  • LOB $40.64
  • EVO $4.63
  • Average True Range (ATR)
  • LOB 1.32
  • EVO 0.18
  • MACD
  • LOB 0.07
  • EVO -0.04
  • Stochastic Oscillator
  • LOB 71.86
  • EVO 14.29

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: